Elequin Capital’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-459
Closed -$4.99K 531
2023
Q4
$4.99K Hold
459
﹤0.01% 269
2023
Q3
$4.96K Hold
459
﹤0.01% 285
2023
Q2
$4.8K Hold
459
﹤0.01% 376
2023
Q1
$4.67K Hold
459
﹤0.01% 225
2022
Q4
$4.69K Sell
459
-10
-2% -$101 ﹤0.01% 537
2022
Q3
$5K Buy
+469
New +$4.66K ﹤0.01% 357

Elequin Capital's PEPL Position: Q1 2024 in Review

Elequin Capital sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2024, closing a stake of 459 shares — an estimated $4.99K sold.

Elequin Capital first reported a position in PEPL in Q3 2022 and held it in 6 quarters. The position peaked at $5K in Q3 2022. 0 funds tracked by Wall St. Rank hold PEPL as of Q1 2024.

  • Elequin Capital reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2024 after selling out during the quarter.
  • Elequin Capital sold 459 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2024, an estimated $4.99K.
  • Elequin Capital first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q3 2022 and held it in 6 quarters.
  • Elequin Capital's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $5K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2024.

Based on Elequin Capital's 13F filing for Q1 2024, filed 15 May 2024.